Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.13.3NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
FL.13.3NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
EG.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.7NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
EG.7NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
BN.1.3.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BN.1.3.5NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
BN.1.3.5NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
XCF.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XCF.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
XCF.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
XCCECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XCCNCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
XCCNUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
FK.1.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FK.1.5NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
FK.1.5NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
FL.21.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.21.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
FL.21.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
FP.2.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FP.2.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
FP.2.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
XBB.1.5.92ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.92NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
XBB.1.5.92NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
XBB.1.5.42ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.42NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-4914.61China
XBB.1.5.42NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
FL.35.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.35.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
FL.35.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
KP.3.2.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KP.3.2.5NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
KP.3.2.5NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
LU.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LU.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-17999.1China
LU.2NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
LF.3.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LF.3.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
LF.3.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
LB.1.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LB.1.7NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
LB.1.7NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
JN.1.16.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.16.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
JN.1.16.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
LW.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LW.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
LW.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used